Joint symptoms and health-related quality of life in postmenopausal women with breast cancer who completed 5 years of anastrozole-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Joint symptoms and health-related quality of life in postmenopausal women with breast cancer who completed 5 years of anastrozole

Published:2015-07-08 Issue:2 Volume:24 Page:683-689
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Yagata Hiroshi,Ohtsu Hiroshi,Komoike Yoshifumi,Saji Shigehira,Takei Hiroyuki,Nakamura Toshitaka,Ohashi Yasuo,Iwase Takuya,Shimozuma Kojiro

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-015-2830-6.pdf

Reference34 articles.

1. Coombes RC, Hall E, Gibson LJ, et al (2004) A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350:1081–1092

2. Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists’ Group, Forbes JF, Cuzick J, Buzdar A, Howell A, Tobias JS, Baum M (2008) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol 9:45–53

3. Regan MM, Neven P, Giobbie-Hurder A, et al (2011) Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. Lancet Oncol 12:1101–1108

4. Mouridsen HT (2006) Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women. Curr Med Res Opin 22:1609–1621

5. Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, Hoctin-Boes G, Houghton J, Locker GY, Tobias JS, ATAC Trialists’ Group (2005) Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet 365:60–62

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health-related quality of life of women with breast cancer being treated with hormone therapy: A scoping review;Journal of Oncology Pharmacy Practice;2023-04-06

2. Quality of life in Spanish postmenopausal breast cancer patients with localized disease who finish endocrine treatment: a prospective study;Menopause;2023-04-04

3. Symptom Profiles and Related Factors Among Breast Cancer Patients Undergoing Endocrine Therapy;Cancer Nursing;2022-12-01

4. Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment;Supportive Care in Cancer;2022-09-06

5. Psychometric assessment of the Chinese version of the Oxford Knee Score in breast cancer survivors experiencing hormone treatment-related knee dysfunction;Asia-Pacific Journal of Oncology Nursing;2022-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3